ESTEVE Secures Caprelsa Rights in Major Pharma Expansion Driven by Dentons Guidance
Deal News | Jul 04, 2025 | Dentons
ESTEVE, a global pharmaceutical company, has acquired the rights to Caprelsa, a targeted tyrosine kinase inhibitor, in over 50 countries. This acquisition is a strategic move aligning with ESTEVE's focus on specialized treatments for challenging medical conditions. Caprelsa is used to treat aggressive medullary thyroid cancer, offering a treatment solution when surgery is inadequate. Dentons Paris provided advisory services, facilitated by a team led by partner Anne-Laure Marcerou, exemplifying Dentons' competence in handling complex international pharmaceutical transactions. The deal's completion awaits customary regulatory clearances.
Sectors
- Pharmaceuticals
- Legal Advisory
Geography
- Global – The transaction involved the acquisition of rights to a drug in over 50 countries, indicating a broad international scope.
- France – Dentons Paris provided the advisory services, highlighting France as a crucial location for the deal facilitation.
Industry
- Pharmaceuticals – The acquisition of Caprelsa is significant in the pharmaceutical industry as it expands ESTEVE's portfolio in targeted cancer treatments.
- Legal Advisory – Dentons played a crucial role in advising ESTEVE on the transaction, reflecting the involvement of legal expertise in complex M&A deals in the pharmaceutical sector.
Financials
- Not specified – The financial terms of the acquisition of the Caprelsa rights were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ESTEVE | Buyer | Company | A global pharmaceutical company acquiring Caprelsa rights to expand their treatment offerings for rare diseases. |
| Dentons | Legal Advisor | Company | An international law firm advising ESTEVE on the acquisition of Caprelsa rights. |
| Anne-Laure Marcerou | Lead Partner | Person | Dentons partner leading the transaction advisory team. |
| Nouayba Soltani | Associate | Person | Part of the Dentons advisory team. |
| Nelly Perng | Associate | Person | Part of the Dentons advisory team. |